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Background: Implementation of antibiotic stewardship programmes (ASPs) in hospitals is challenging and there
is a knowledge gap on how to pursue this process efficiently.
Objectives: To evaluate whether audit and feedback (A&F) is a feasible and useful methodology to assess and
support the implementation of ASPs in hospitals.
Methods: A multidisciplinary team performed document reviews and on-site interviews with professionals
involved in the implementation of ASPs. Oral feedback on preliminary findings and areas of improvement were
provided on-site, followed by feedback reports summarizing major findings and recommendations. Descriptive
statistics were used to present number of hospital trusts, interviewees, professions, disciplines, workload and
costs.
Results: All 22 hospital trusts in Norway participated in the A&F conducted October 2017 to April 2019.
Altogether, 446 leaders and healthcare workers were interviewed: 110 leaders, 336 health professionals of
whom 89 were antimicrobial stewardship team members. Median number of days from audits were performed
till reporting were 36 (IQR 30–49). Median workload for auditors per visit was 7 days (6–8). Total costs were
e133 952. Main audit findings were that ASP structures were established in most hospital trusts, but leadership
commitment and implementation of interventions were often lacking. The hospital trusts received feedback on
establishing governance structures, setting local targets, implementing interventions and increased involvement
of nurses.
Conclusions: Nationwide A&F provides a unique and comprehensive insight into the implementation of ASPs in
hospitals and is feasible with a reasonable amount of resources. This approach can identify targets for improved
implementation of ASPs in hospitals.
Introduction
Many countries have developed national action plans outlining
measures needed to combat antimicrobial resistance (AMR).1,2
However, achievements depend on implementation of the
measures, which may be evaluated using different types of data,
e.g. quality indicators (QIs).3,4 However, a qualitative approach
can provide a more in-depth insight into these processes.5 Audit
and feedback (A&F), i.e. any summary of clinical performance of
healthcare over a specified period of time, is one suitable method
for qualitative data collection when applied within a field with
well-defined standards.6 This methodology has been used in vari-
ous topics and settings, but as far as we know, it has not been
applied to assess and support the implementation of antibiotic
stewardship programmes (ASPs) in hospitals.7
In 2016, The Norwegian Ministry of Health and Care services
launched an action plan against AMR.2 ASPs became mandatory
for hospitals and a target was set for reducing the use of five
groups of broad spectrum antibiotics by 30% by the end of 2020
compared with 2012. The Norwegian Advisory Unit for Antibiotic
Use in Hospitals (KAS) were to support the Norwegian hospitals in
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implementing ASPs. As part of this support, KAS together with the
Northern Norway Regional Health Authority (RHA) decided to con-
duct A&F. In this paper, we aim to detail whether A&F is a feasible




A retrospective evaluation study design was used to investigate whether
A&F is a feasible and useful methodology to evaluate the implementation
of ASPs in hospitals.8
Setting
The study was conducted in Norway, a high-income country with 5.4 mil-
lion inhabitants. Antibiotic consumption and AMR rates in Norway are below
the European average.9,10 However, there is large variation in the use of
broad-spectrum antibiotics between hospitals, which cannot be accounted
for by differences in activity or case mix alone.11 Across the country, 48 hos-
pitals are organized into 19 hospital trusts that constitute four RHAs: the
Northern, Central, Western and South-Eastern RHAs. The Ministry of Health
and Care Services finances and owns the RHAs. In addition, three private,
non-profit general hospitals are contracted by the RHAs, i.e. there are 22
hospital trusts in Norway.
The audit and feedback
The A&Fs were conducted by two teams. The Northern RHA team consisted
of two internal auditors and three experts: an infection control physician/
microbiologist (K.G.), a pharmacist (J.U.H.) and an infectious disease (ID)
physician from KAS (P.E.A.). The audit team in the three southern RHAs
comprised an ID physician (P.E.A.) and a pharmacist (M.I.N.), both from KAS.
All audit team members participated in planning the audits, reviewing the
documents and writing the feedback reports, whereas only two professio-
nals conducted the audit on site.
Selection of focus areas and review criteria and the development of an
interview guide were mainly based on the mandatory content of an ASP as
outlined in the Norwegian action plan.2 In addition, we applied the national
guideline on antibiotic use in hospitals, healthcare legislation and assign-
ment agreement documents from the Ministry of Health and Care Services
to the RHAs.12–15
We defined four focus areas: (i) the hospital trusts’ formal/written ASP
documents, such as policies, mandates, organization, targets and mile-
stones; (ii) the hospital trusts’ strategies for how to achieve 30% reduction
in the use of broad-spectrum antibiotics by 2020; (iii) the hospital trusts’
systems for ensuring physicians’ and nurses’ competence and training in
antibiotic prescribing; and (iv) the hospital trusts’ antibiotic prescribing prac-
tices and the application of the national guideline on antibiotic use.12
Two to six review criteria were developed for each focus area, defining the
standards to which the observations were compared.16 An interview guide
with a total of 40 questions was developed. See Table S1 for the detailed
interview guide (available as Supplementary data at JAC-AMR Online).
All 22 hospital trusts in Norway were invited via a letter to the hospital
management. Participation was mandatory for the four northern hospital
trusts as the Northern RHA had ordered the audit, whereas it was voluntary
for the 18 remaining hospital trusts.
Data were collected in two steps. First, relevant documents were
obtained from the hospital trusts, either through an online search or by re-
quest. Relevant documents were management and milestone plans, an
overview of antimicrobial stewardship (AMS) team members, and antibiotic
consumption and antibiotic resistance reports.
Secondly, data were collected during on-site visits. We visited one
hospital in each hospital trust, primarily the largest hospital, except for the
largest hospital trust with two university hospitals, where we visited both.
The programme for each on-site visit (duration 7–14 h) included a start-up
meeting, semi-structured interviews with various professionals involved in
antibiotic prescribing or implementation of the ASP, and a final meeting
(Table 1). We primarily targeted departments with high antibiotic con-
sumption and ensured that the interviewed leaders, physicians and nurses
were employed at the same units. Notes were taken during the interviews,
but they were not recorded.
The hospital trusts were given immediate feedback in the final meet-
ings, meaning preliminary findings and advice for further implementation
of the ASPs. Additionally, findings from the audit were presented in a feed-
back report to each hospital trust (8–15 pages) which provided five to nine
points for improvement. Each hospital trust was given the opportunity to
comment on the preliminary report before it was finalized and sent to the
hospital trust management and published on KAS’ and the Northern RHA’s
websites.
Analyses
Descriptive statistical analyses were performed using Microsoft Excel ver-
sion 16, to present the participating hospital trusts, the interviewees, A&F
timeline, auditors’ workload and costs. Data on auditors’ workload were
obtained from their working schedules, which included planning, travel,
auditing and writing of reports. Costs were calculated by summarizing audi-
tors’ travel expenses and labour costs for all professionals involved in the
intervention (auditors, interviewees and administrative staff organizing the
visits). Data on the auditors’ travel expenses were obtained from the hospi-
tals’ electronic expense management systems. Since salaries between pro-
fessions and geographical areas vary, average daily salary expenses for an
employee in the Norwegian healthcare system were calculated based on
salary expenses for the auditors, including employee costs.
Ethics
The audits were performed as part of the quality improvement of care in
healthcare institutions, therefore ethical approval was not required.
The participants were informed that the reports would be published on a
website, i.e. made publicly available. Data were presented anonymously,
with an exception for the Directors of Research and Development who were
identifiable in the reports.
Results
Participants
All 22 hospital trusts in Norway agreed to participate and
were included in the A&F. In total, 446 leaders and healthcare
workers were interviewed. All hospital trusts were represented by
a Director of Research and Development, managers, health profes-
sionals and AMS team members (Table 2).
Participating health professionals included physicians (senior
consultants and residents), nurses and pharmacists. The majority
of them worked at departments of medicine, but departments of
surgery, intensive care and paediatrics were also represented
(Figure 1). The AMS team members were physicians, nurses
and pharmacists by profession, though the vast majority were
physicians (Figure 2).
Timeline
The audits were performed from October 2017 to April 2019, with
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Overall, the time from the audits being performed to the hos-
pital trusts receiving preliminary reports was a median of 15 days
(IQR 9–25 days) and the time to final reports being published was
a median of 36 days (IQR 30–49). The median (IQR) time from the
audits being performed to preliminary reports being received by
the hospital trusts in three southern RHAs and the Northern RHA
Table 1. Example of an on-site visit programme
Time Activity Participants/interviewees Comment
8:30–9:00 Start-up meeting Leaders and all interviewees Presentation of purpose/aim, auditors
and programme for the day





10:30–11:15 Group interview AMS team
11:30–12:00 Group interview Senior consultants
12:45–13:15 Group interview Residents
13:30–14:00 Group interview Nurses (and secretary)
14:00–15:00 Review of results Auditors
15:00–15:45 Final meeting Leaders and all interviewees Presentation of preliminary findings and
areas of improvements for all participants
aOr other/equivalent Director representing the hospital management.
Table 2. Overview of all interviewees (n"446) in the 22 participating hospital trusts in Norway
Hospital trust Director of Research and Development Leaders Health professionals AMS team members Sum
Northern RHA
1 1 4 9 1 15
2 1 4 10 2 17
3 1 4 11 2 18
4 1 3 9 2 15
Central RHA
1 1 3 10 4 18
2 1 6 14 4 25
3 1 2 10 4 17
South-Eastern RHAa
1 1 3 9 6 19
2 1 4 10 5 20
3 1 4 11 5 21
4 1 3 12 4 20
5 1 3 12 5 21
6 1 3 12 3 19
7 1 8 21 6 36
8 1 4 11 6 22
9 1 4 12 5 22
10 1 3 11 6 21
Western RHAb
1 1 6 12 4 23
2 1 3 9 4 17
3 1 4 9 2 16
4 1 4 11 3 19
5 1 6 12 6 25
Total 22 88 247 89 446
a Includes two private hospitals.
b Includes one private hospital.
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was 14 days (9–18) and 79 days (61–98), respectively. Time till
final reports were published was 33 days (28–38) and 108 days
(90–127), respectively. In the Northern RHA, it lasted 137 days
(119–156) until the reports were approved by the regional hospital
trust board.
Workload and costs
Total workload for all auditors per visit was median 7 days (IQR
6–8).
Total cost of the A&F was e133 952, of which 14% were travel
expenses and 86% were salaries for auditors, interviewees and
administrative staff (Table 3).
Main audit findings and feedback
Our main findings were that ASP structures were put in place in
most hospital trusts. Most of them had a formal/written ASP policy
document, AMS was identified as a priority objective by the
management and a formal organizational multidisciplinary team
responsible for AMS was established. All hospital trusts bench-
marked their antibiotic consumption in line with the national
target of a 30% reduction in use of broad spectrum antibiotics.
Additionally, clinicians were familiar with the national guideline on
antibiotic use, and they reported that they adhered to the guide-
line recommendations. However, beyond having these structures
put in place there was a general lack of leadership commitment
and scarce implementation of AMS interventions. Thus, in general
the hospital trusts were given the following feedback: (i) to put
in place a governance structure for the programmes; (ii) to set
specific targets for improvement of antibiotic use at depart-
ment and ward level; (iii) to implement evidence-based stew-
ardship interventions, such as A&F of antibiotic use and
mandatory review of antibiotic therapy within 48–72 h on the
departments and wards; (iv) to define the nurses’ role in the
multidisciplinary teams; and (v) to ensure that physicians and
nurses had relevant competences and training in antibiotic
prescribing and use.
Discussion
When investigating the feasibility and value of applying A&F to
evaluate implementation of ASPs in hospital trusts in Norway, we
found that with a reasonable use of resources, it was possible to
obtain valuable information and provide timely feedback to each
hospital addressing explicit targets for further implementation
of their ASPs.
To our knowledge, this is the first published evaluation study
on A&F used as a systematic approach to assess and support the
implementation of ASPs in hospital trusts nationwide. There are
studies using surveys to evaluate implementation of ASPs, but
these publications do not evaluate the survey methodology’s
feasibility and value.17,18
The audit generated a substantial amount of data, which
identified several targets for further implementation of ASPs in
Norwegian hospitals. A major finding was the lack of governance
structures. This urgently needs to be addressed as hospital
leadership commitment is considered to be an important core
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programmes.2,8 Furthermore, specific targets were rarely defined
on the department and ward levels and evidence-based steward-
ship measures were only sporadically implemented, which is a
prerequisite for implementation and impact of an ASP.19 The
limited involvement of nurses in AMS activities represents an
opportunity to strengthen the AMS task force, as nurses consti-
tute the majority of healthcare staff and are central in caring for
patients with infectious diseases.20 A reassuring finding from
the audit was the reported adherence to the national guideline
on antibiotic use, which is associated with favourable patient
outcomes and reduced consumption of broad-spectrum
antibiotics.21–23
According to a Cochrane review, A&F is most effective when
conducted by a supervisor or a colleague.6 Therefore, the on-site
audit team consisted of at least one AMS expert. Furthermore, the
impact of an A&F may increase when feedback is delivered both
orally and in writing, providing the target audience with well-
defined targets and an action plan for improvement. In this ap-
proach, the hospital trusts were provided several specific points for
improvement, both orally and through the feedback reports, but
each hospital trust was responsible for development of an action
plan. The literature indicates that timeliness also may influence
the effectiveness of an A&F.24 Ideally, the time period between the
audits and the distribution of the feedback reports could have
been shorter. However, oral feedback was provided immediately
after completion of the on-site audit.
This study indicates that A&F was a feasible and sound meth-
odology to assess and support nationwide implementation of
ASPs in Norwegian hospital trusts. Norway has a small population
and a mainly publicly funded healthcare system, so our findings
may be most valid for similar countries, such as the Nordic coun-
tries. Still, regions with healthcare networks and an acknowledged
and financed authority within AMS may also benefit from a similar
approach. This is highly warranted in order to validate and supple-
ment our findings.
Furthermore, there is a need for studies evaluating the efficacy
of the A&F approach to support the implementation of ASPs.
From January 2021 onward, KAS has initiated a follow-up of all the
Norwegian hospital trusts to get an update on the implementation
of ASPs in the hospitals and evaluate the impact of the A&F. The
follow-up meetings are standardized by using a semi-structured
interview guide when interviewing AMS team members and
Research and Development Directors. In a future publication, the
more specific A&F findings will be analysed in light of the findings
from the follow-up meetings, to identify facilitators and barriers
for implementation of ASPs, thereby addressing an important
knowledge gap in AMS.25
A major strength of this study is that all hospital trusts in
Norway participated in the A&F with a substantial number of
professionals with diverse backgrounds, providing an extensive
amount of data. Another strength is the study’s uniqueness in
evaluating A&F as a method to assess nationwide implementation
of ASPs in hospitals. A limitation is that the A&F was designed as a
quality improvement measure, and not a scientific study, implying
retrospective data collection. Furthermore, some of the professio-
nals in the team evaluating the A&F were responsible for the A&F,
potentially interpreting data more favourably. This was tentatively
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Figure 3. The timeline for the audit and feedback. Letter and number correspond to when the hospital trusts in each regional health trust were vis-
ited/audited. Length of box corresponds to time from on-site visit till report/feedback was finalized. N, Northern Regional Health Trust (4 hospital
trusts); W, Western Regional Health Trust (5 hospital trusts); C, Central Regional Health Trust (3 hospital trusts); SE, South-Eastern Regional Health
Trust (10 hospital trusts).
Table 3. Calculation of audit and feedback costs
Expenses Sum (e) Proportion of expenses (%)
Travel 19 405 14
Salary auditors 68 308 51
Salary interviewees 37 091 28
Salary administrative staff 9148 7
Total 133 952 100
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Conclusions
In this evaluation study, we found that A&F is a feasible and valu-
able methodology to assess nationwide implementation of ASPs
in hospitals. Furthermore, it can identify relevant targets for
improved implementation of the programmes. This approach can
be applied in other healthcare settings and may generate new
knowledge on the implementation of ASPs.
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